Please try another search
As of March 11, 2016, MATRX Pharmaceuticals S.A. was acquired by CoGyn Pharmaceuticals, Inc., in a reverse merger transaction. MATRX Pharmaceuticals S.A., a specialty pharmaceutical company, develops systems for the controlled dispensing of generic drugs with the use of solid and semi-solid drug carriers for use of general or topical, and targeting a specific body. Its systems primarily focus on the treatment of diseases and disorders of women, and the treatment of tumors and prevention of sexually transmitted diseases. The company was formerly known as CoGyn Pharmaceuticals SA and changed its name to MATRX Pharmaceuticals S.A. in March 2016. MATRX Pharmaceuticals S.A. is based in Wroclaw, Poland.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review